Tonix Pharma (TNXP.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec17

Noble Financial Analyst Reiterates Buy Rating for Tonix Pharma

14:52

Dec16

Tonix Pharmaceuticals Licenses TNX-4900 for Chronic Pain Treatment

12:07

Nov24

Tonix Pharmaceuticals Receives FDA Approval for TNX-102 SL Phase 2 Study

12:16

Nov11

Tonix Pharma released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 3.29 M (forecast USD 2.3 M), actual EPS USD -3.5874 (forecast USD -3.585)

04:00

Tonix Pharma released FY2025 9 Months Earnings on November 10 (EST), actual revenue USD 7.717 M, actual EPS USD -10.2877

04:00

Oct7

Tonix Pharmaceuticals Holding Corp. Obtains FDA Approval for Fibromyalgia Drug and Plans for Market Launch

09:43

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 3.29 M, Net Income -32.01 M, EPS -3.5874

Aug11

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.998 M, Net Income -28.27 M, EPS -3.8584

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 2.429 M, Net Income -16.83 M, EPS -2.8392

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change